Why The Humble Swab Could Be A Seriously Disruptive Element In The MDR And IVDR
Executive Summary
Health care is about to suffer a major setback and some devices and IVDs are going to have to be held back from the market if the regulatory status of the humble swab is not sufficiently recognized and urgently addressed.
You may also be interested in...
EU MDR Notified Body Designations Could Soar By A Third By End Of 2021
There could be 28 notified body designations in total under the Medical Device Regulation by the end of 2021. But there is cause for concern over designations under the IVD Regulation, which are lagging far behind.
EU Regulatory Roundup, September 2023: Dismantling Regulatory Barriers To Medtech Innovation
The call for more to be done about the EU’s regulatory hurdles to innovation, as well as for improvements to governance, has now grown to a crescendo. While the EU looks at how best to move forward, innovation in the UK is benefiting from greater regulatory freedoms.
Commission Text Clarifying Timelines For Annex XVI Devices May Leave Companies Dazed
The revised timelines around products generally used for aesthetic purposes, a small subset of products falling under the Medical Device Regulation, create their own microsphere of complexity.